Related references
Note: Only part of the references are listed.24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
E. Randy Craven et al.
DRUGS (2020)
The Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study
Paula Anne Newman-Casey et al.
OPHTHALMOLOGY (2020)
Matrix Metalloproteinases and Glaucoma Treatment
Robert N. Weinreb et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2020)
Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)
Felipe A. Medeiros et al.
OPHTHALMOLOGY (2020)
Dose-Response of Intracameral Bimatoprost Sustained-Release Implant and Topical Bimatoprost in Lowering Intraocular Pressure
Susan S. Lee et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2019)
Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues
Jennifer R. Seal et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2019)
Bimatoprost Sustained-Release Implants for Glaucoma Therapy: 6-Month Results From a Phase I/II Clinical Trial
Richard A. Lewis et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2017)
Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma A Systematic Review and Network Meta-analysis
Tianjing Li et al.
OPHTHALMOLOGY (2016)
Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases
Hiroshi Yamada et al.
BMC OPHTHALMOLOGY (2016)
Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1
Florent Aptel et al.
ACTA OPHTHALMOLOGICA (2015)
The Most Common Barriers to Glaucoma Medication Adherence A Cross-Sectional Survey
Paula Anne Newman-Casey et al.
OPHTHALMOLOGY (2015)
Patterns of Glaucoma Medication Adherence over Four Years of Follow-Up
Paula Anne Newman-Casey et al.
OPHTHALMOLOGY (2015)
Why Do People (Still) Go Blind from Glaucoma?
Remo Susanna et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2015)
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040 A Systematic Review and Meta-Analysis
Yih-Chung Tham et al.
OPHTHALMOLOGY (2014)
Rates of visual field progression in clinical glaucoma care
Anders Heijl et al.
ACTA OPHTHALMOLOGICA (2013)
Lifetime Risk of Blindness in Open-Angle Glaucoma
Dorothea Peters et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)
Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension
Gail F. Schwartz et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
The Structure and Function Relationship in Glaucoma: Implications for Detection of Progression and Measurement of Rates of Change
Felipe A. Medeiros et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Effect of Treatment on the Rate of Visual Field Change in the Ocular Hypertension Treatment Study Observation Group
Carlos Gustavo De Moraes et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
The Relationship between Glaucoma Medication Adherence, Eye Drop Technique, and Visual Field Defect Severity
Betsy Sleath et al.
OPHTHALMOLOGY (2011)
Compliance and knowledge about glaucoma in patients at tertiary glaucoma units
Kaweh Mansouri et al.
INTERNATIONAL OPHTHALMOLOGY (2011)
Biodegradable Implants for Sustained Drug Release in the Eye
Susan S. Lee et al.
PHARMACEUTICAL RESEARCH (2010)
Comparing Adherence and Persistence Across 6 Chronic Medication Classes
Jason Yeaw et al.
JOURNAL OF MANAGED CARE PHARMACY (2009)
The Impact of Ocular Adverse Effects in Patients Treated With Topical Prostaglandin Analogs: Changes in Prescription Patterns and Patient Persistence
Thom J. Zimmerman et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2009)
Effect of Bimatoprost, Latanoprost, and Unoprostone on Matrix Metalloproteinases and Their Inhibitors in Human Ciliary Body Smooth Muscle Cells
Yen Hoong Ooi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Side Effects Associated with Prostaglandin Analog Therapy
Albert Alm et al.
SURVEY OF OPHTHALMOLOGY (2008)
Bimatoprost, prostamide activity, and conventional drainage
Zhou Wan et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells
Dong-Jin Oh et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
The number of people with glaucoma worldwide in 2010 and 2020
HA Quigley et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension - An evidence-based review
CMG Olthoff et al.
OPHTHALMOLOGY (2005)
Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide
M Richter et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Reduction of intraocular pressure and glaucoma progression - Results from the early manifest glaucoma trial
A Heijl et al.
ARCHIVES OF OPHTHALMOLOGY (2002)